CTMX - CytomX upgraded at Piper Sandler on validation of cancer therapeutics platform
2024-05-28 09:21:20 ET
More on CytomX
- CytomX: CX-904 Tumor Treatment Data Might Get Ball Rolling
- CytomX Therapeutics: I'm Bullish; There's More Than One Masked Immunotherapy Company In Town
- CytomX slides after early data for Amgen-partnered cancer drug
- CytomX teams up with Merck for CX-801 clinical study
- CytomX Therapeutics, Inc. (CTMX) Q1 2024 Earnings Call Transcript